Using β-Lactamase and NanoLuc Luciferase Reporter Gene Assays to Identify Inhibitors of the HIF-1 Signaling Pathway
- PMID: 27518620
- PMCID: PMC5375166
- DOI: 10.1007/978-1-4939-6346-1_3
Using β-Lactamase and NanoLuc Luciferase Reporter Gene Assays to Identify Inhibitors of the HIF-1 Signaling Pathway
Abstract
The hypoxia-inducible factor 1 (HIF-1) is a transcriptional factor involved in the regulation of oxygen within cellular environments. In hypoxic tissues or those with inadequate oxygen concentrations, activation of the HIF-1 transcription factor allows for subsequent activation of target gene expression implicated in cell survival. As a result, cells proliferate through formation of new blood vessels and expansion of vascular systems, providing necessary nourishment needed of cells. HIF-1 is also involved in the complex pathophysiology associated with cancer cells. Solid tumors are able to thrive in hypoxic environments by overactivating these target genes in order to grow and metastasize. Therefore, it is of high importance to identify modulators of the HIF-1 signaling pathway for possible development of anticancer drugs and to better understand how environmental chemicals cause cancer. Using a quantitative high-throughput screening (qHTS) approach, we are able to screen large chemical libraries to profile potential small molecule modulators of the HIF-1 signaling pathway in a 1536-well format. This chapter describes two orthogonal cell based assays; one utilizing a β-lactamase reporter gene incorporated into human ME-180 cervical cancer cells, and the other using a NanoLuc luciferase reporter system in human HCT116 colon cancer cells. Cell viability assays for each cell line are also conducted respectively. The data from this screening platform can be used as a gateway to study mode of action (MOA) of selected compounds and drug classes.
Keywords: Beta-lactamase; Cancer; Drug; FRET; Fluorescence resonance energy transfer; Genome editing; Hypoxia inducible factor 1; Hypoxia response elements; Luciferase; NanoLuc; Quantitative high-throughput screening; Reporter gene; qHTS.
Figures
Similar articles
-
Identification of approved and investigational drugs that inhibit hypoxia-inducible factor-1 signaling.Oncotarget. 2016 Feb 16;7(7):8172-83. doi: 10.18632/oncotarget.6995. Oncotarget. 2016. PMID: 26882567 Free PMC article.
-
Identification of chemical compounds that induce HIF-1alpha activity.Toxicol Sci. 2009 Nov;112(1):153-63. doi: 10.1093/toxsci/kfp123. Epub 2009 Jun 5. Toxicol Sci. 2009. PMID: 19502547 Free PMC article.
-
Identification of small molecule compounds that inhibit the HIF-1 signaling pathway.Mol Cancer. 2009 Dec 9;8:117. doi: 10.1186/1476-4598-8-117. Mol Cancer. 2009. PMID: 20003191 Free PMC article.
-
Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.J Exp Clin Cancer Res. 2007 Mar;26(1):39-50. J Exp Clin Cancer Res. 2007. PMID: 17550131 Review.
-
Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications.J Med Chem. 2019 Jun 27;62(12):5725-5749. doi: 10.1021/acs.jmedchem.8b01596. Epub 2019 Feb 8. J Med Chem. 2019. PMID: 30682255 Review.
Cited by
-
Curcumin and NCLX inhibitors share anti-tumoral mechanisms in microsatellite-instability-driven colorectal cancer.Cell Mol Life Sci. 2022 May 8;79(6):284. doi: 10.1007/s00018-022-04311-4. Cell Mol Life Sci. 2022. PMID: 35526196 Free PMC article.
-
BaroFuse, a novel pressure-driven, adjustable-throughput perfusion system for tissue maintenance and assessment.Heliyon. 2016 Dec 9;2(12):e00210. doi: 10.1016/j.heliyon.2016.e00210. eCollection 2016 Dec. Heliyon. 2016. PMID: 27995203 Free PMC article.
-
NanoFIRE: A NanoLuciferase and Fluorescent Integrated Reporter Element for Robust and Sensitive Investigation of HIF and Other Signalling Pathways.Biomolecules. 2023 Oct 19;13(10):1545. doi: 10.3390/biom13101545. Biomolecules. 2023. PMID: 37892227 Free PMC article.
References
-
- Jiang BH, Semenza GL, Bauer C, Marti HH. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. The American journal of physiology. 1996;271(4 Pt 1):C1172–1180. - PubMed
-
- Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. The Journal of biological chemistry. 1995;270(3):1230–1237. - PubMed
-
- Salceda S, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. The Journal of biological chemistry. 1997;272(36):22642–22647. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials